Therefore, in this study, the meta-analysis method was used to systematically evaluate the relationship between CYP2A13 gene polymorphism and lung cancer susceptibility, in order to provide a basis for exploring clinical drug targets and cancer prevention. This evidence concerns the gene CYP2A13 and cancer.